GLP-1 agonists and neurovascular diseases
Overnutrition has led to persistent health issues, such as obesity and metabolic syndrome in humans. Obesity is directly linked to chronic low-grade inflammation, connecting our metabolic environment to neurodegenerative diseases.
Glucagon-like peptide-1 receptor (GLP-1R) agonists has been extensively used to manage weight and address metabolic defects.
How GLP-1R agonism impacts brain health is not clearly understood and recent literature suggests that GLP-1R agonism may have the capacity to shape the neurovascular landscape.
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(24)00367-X
https://sciencemission.ayurmatrika.com/GLP-1-programs-the-neurovascular-landscape
